The nature of biopsies with "borderline rejection" and prospects for eliminating this category

American Journal of Transplantation

Volumn 12, Issue 1, 2012, Pages 191-201

  De Freitas, D G ^a,b   Sellares J ^a   Mengel, M ^a,c   Chang, J ^a   Hidalgo, L G ^a   Famulski, K S ^a,c   Sis, B ^a,c   Einecke, G ^d   Halloran, P F ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF ALBERTA   (Canada)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Banff classification; borderline; kidney transplantation; T cell mediated rejection

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATROPHY; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SCAR FORMATION; SCHOOL CHILD; SCORING SYSTEM; T CELL MEDIATED REJECTION; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; BIOPSY; CHILD; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84855944456     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03784.x     Document Type: Article

References (28)

1. Sis B, Mengel M, Haas M, et al,. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
2. Marcussen N, Lai R, Olsen TS, Solez K,. Morphometric and immunohistochemical investigation of renal biopsies from patients with transplant ATN, native ATN, or acute graft rejection. Transplant Proc 1996; 28: 470-476. (Pubitemid 26073825)
3. Solez K, Racusen LC, Marcussen N, et al,. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 1993; 43: 1058-1067. (Pubitemid 23137090)
4. Dahan K, Audard V, Roudot-Thoraval F, et al,. Renal allograft biopsies with borderline changes: Predictive factors of clinical outcome. Am J Transplant 2006; 6: 1725-1730. (Pubitemid 43945816)
5. Seron D, Moreso F, Bover J, et al,. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51: 310-316. (Pubitemid 27064552)
6. Mengel M, Chang J, Kayser D, et al,. The molecular phenotype of six-week protocol biopsies from human renal allografts: Reflections of prior injury but not future course. Am J Transplant 2011; 11: 708-718.
7. Veronese FV, Manfro RC, Roman FR, et al,. Reproducibility of the Banff classification in subclinical kidney transplant rejection. Clin Transplant 2005; 19: 518-521. (Pubitemid 40990663)
8. Sellares J, de Freitas DG, Mengel M, et al,. Inflammation lesions in kidney transplant biopsies: Association with survival is due to the underlying diseases. Am J Transplant 2011; 11: 489-499.
9. Furness PN, Taub N, Assmann KJ, et al,. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003; 27: 805-810. (Pubitemid 36617518)
10. Saad R, Gritsch HA, Shapiro R, et al,. Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff schema. Transplant 1997; 64: 992-995. (Pubitemid 27446764)
11. Meehan SM, Siegel CT, Aronson AJ, et al,. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol 1999; 10: 1806-1814. (Pubitemid 29364681)
12. Schweitzer EJ, Drachenberg CB, Anderson L, et al,. Significance of the Banff borderline biopsy. Am J Kidney Dis 1996; 28: 585-588. (Pubitemid 26337599)
13. Hidalgo LG, Einecke G, Allanach K, et al,. The transcriptome of human cytotoxic T-cells: Measuring the burden of CTL-associated transcripts in human kidney transplants. Am J Transplant 2008; 8: 637-646. (Pubitemid 351287556)
14. Reeve J, Einecke G, Mengel M, et al,. Diagnosing rejection in renal transplants: A comparison of molecular- and histopathology-based approaches. Am J Transplant 2009; 9: 1802-1810.
15. Famulski KS, Einecke G, Sis B, et al,. Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant 2010; 10: 810-820.
16. Einecke G, Reeve J, Sis B, et al,. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010; 120: 1862-1872.
17. Mueller TF, Einecke G, Reeve J, et al,. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 2712-2722. (Pubitemid 350045779)
18. Einecke G, Sis B, Reeve J, et al,. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
19. Sellares J, de Freitas DG, Mengel M, et al,. Inflammation lesions in kidney transplant biopsies: Association with survival is due to the underlying diseases. Am J Transplant 2011; 11: 489-499.
20. Famulski KS, Einecke G, Reeve J, et al,. Changes in the transcriptome in allograft rejection: IFN-γ induced transcripts in mouse kidney allografts. Am J Transplant 2006; 6: 1342-1354. (Pubitemid 44030317)
21. Broderick G, Schaefer C, Einecke G, Halloran PF,. Identifying changes in gene regulatory motifs in rejection of human kidney transplants. Long Island, NY: Cold Spring Harbor Laboratory, 2007; abstract 35.
22. Sis B, Lategan B, Bagnasco S, et al,. Significance of isolated vasculitis (v1) in kidney transplants: A multicenter observational study. Am J Transplant 2011; 11: 58.
23. Bunnag S, Einecke G, Reeve J, et al,. Molecular correlates of renal function in kidney transplant biopsies. J Am Soc Nephrol 2009; 20: 1149-1160.
24. Mengel M, Gwinner W, Schwarz A, et al,. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7: 356-365. (Pubitemid 46096328)
25. Matas AJ, Solez K,. From first principles-tubulitis in protocol biopsies and learning from history. Am J Transplant 2001; 1: 4-5.
26. Bonventre JV,. Kidney injury molecule-1 (KIM-1): A specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl 2008; 241: 78-83. (Pubitemid 351883663)
27. Wipff PJ, Hinz B,. Integrins and the activation of latent transforming growth factor beta 1-An intimate relationship. Eur J Cell Biol 2008; 87: 601-615.
28. Mengel M, Reeve J, Bunnag S, et al,. Scoring total inflammation is superior to the current banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant 2009; 9: 1859-1867.